Mounjaro 7.5mg KwikPen – Powerful Weight Loss & Diabetes Control Injection

About Mounjaro 7.5mg KwikPen

Mounjaro 7.5mg KwikPen is a prescription injection used to treat type 2 diabetes and support weight loss in adults with obesity (BMI ≥30) or overweight (BMI ≥27). It works by increasing insulin sensitivity, reducing hunger, and slowing digestion to keep you full longer.

How Mounjaro 7.5mg KwikPen Works

• Activates GLP-1 & GIP hormone receptors

• Boosts insulin release when blood sugar is high

• Reduces glucagon secretion to prevent excess glucose

• Slows gastric emptying for appetite control

• Supports effective long-term weight management

Uses of Mounjaro 7.5mg KwikPen

• Type 2 Diabetes Mellitus (improves glycemic control)

• Obesity management & weight reduction

Benefits

• Once-weekly convenient injection

• FDA-approved for type 2 diabetes and weight loss

• Supports blood sugar balance and weight reduction

• Reduces appetite and food cravings

• Can improve obesity-related health conditions

Administration

• Subcutaneous injection (abdomen, thigh, or upper arm)

• Rotate injection sites weekly

• Take at the same time each week

Side Effects

• Nausea, vomiting, constipation, diarrhea

• Abdominal pain, indigestion

• Most side effects are mild and improve with time

Safety Information

• Not suitable for patients with history of thyroid cancer (MEN2)

• Avoid during pregnancy and breastfeeding

• May reduce the effectiveness of oral contraceptives – use additional protection

• Safe in kidney and liver disease under doctor supervision

Storage

• Store in refrigerator (2°C–8°C), do not freeze

• Keep away from children